• English
    • Deutsch
View Item 
  •   OPARU Home
  • Universitätsklinikum Ulm
  • Publikationsnachweise
  • View Item
  •   OPARU Home
  • Universitätsklinikum Ulm
  • Publikationsnachweise
  • View Item
  • English 
    • English
    • Deutsch
  • Login
JavaScript is disabled for your browser. Some features of this site may not work without it.

A phase II trial (AGO 2.11) in platinum-resistant ovarian cancer: a randomized multicenter trial with sunitinib (SU11248) to evaluate dosage, schedule, tolerability, toxicity and effectiveness of a multitargeted receptor tyrosine kinase inhibitor monotherapy

Erstveröffentlichung
2012
Metadata only
Search for full text
Wissenschaftlicher Artikel


Authors
Baumann, K. H.
du Bois, A.
Meier, W.
Rau, J.
Wimberger, P.
et al.
Institutions
UKU. Klinik für Frauenheilkunde und Geburtshilfe
Published in
Annals of Oncology ; 23 (2012), 9. - S. 2265-2271. - ISSN 0923-7534. - eISSN 1569-8041
Link to publication
https://dx.doi.org/10.1093/annonc/mds003
Keywords
angiogenesis inhibitor; ovarian cancer; platinum resistant; sunitinib; RECURRENT EPITHELIAL OVARIAN; ENDOTHELIAL GROWTH-FACTOR; ANTITUMOR-ACTIVITY; INTERGROUP TRIAL; CARCINOMA; PACLITAXEL; CARBOPLATIN; GUIDELINES; CISPLATIN
Dewey Decimal Group
DDC 610 / Medicine & health

Metadata
Show full item record

About OPARU | Contact Us
Impressum | Privacy statement
 

 

Advanced Search

Browse

All of OPARUCommunities & CollectionsFacultiesInstitutionsPersonsResource typesUlm SerialsDewey Decimal ClassesFundingThis CollectionFacultiesInstitutionsPersonsResource typesUlm SerialsDewey Decimal ClassesFunding

My Account

LoginRegister

Statistics

View Usage Statistics

About OPARU | Contact Us
Impressum | Privacy statement